Literature DB >> 19428925

Cost-benefit comparisons of investments in improved water supply and cholera vaccination programs.

Marc Jeuland1, Dale Whittington.   

Abstract

This paper presents the first cost-benefit comparison of improved water supply investments and cholera vaccination programs. Specifically, we compare two water supply interventions -- deep wells with public hand pumps and biosand filters (an in-house, point-of-use water treatment technology) -- with two types of cholera immunization programs with new-generation vaccines -- general community-based and targeted and school-based programs. In addition to these four stand-alone investments, we also analyze five combinations of water and vaccine interventions: (1) borehole+hand pump and community-based cholera vaccination, (2) borehole+hand pump and school-based cholera vaccination, (3) biosand filter and community-based cholera vaccination, (4) biosand filter and school-based cholera vaccination, and (5) biosand filter and borehole+hand pump. Using recent data applicable to developing country locations for parameters such as disease incidence, the effectiveness of vaccine and water supply interventions against diarrheal diseases, and the value of a statistical life, we construct cost-benefit models for evaluating these interventions. We then employ probabilistic sensitivity analysis to estimate a frequency distribution of benefit-cost ratios for all four interventions, given a wide variety of possible parameter combinations. Our results demonstrate that there are many plausible conditions in developing countries under which these interventions will be attractive, but that the two improved water supply interventions and the targeted cholera vaccination program are much more likely to yield attractive cost-benefit outcomes than a community-based vaccination program. We show that implementing community-based cholera vaccination programs after borehole+hand pump or biosand filters have already been installed will rarely be justified. This is especially true when the biosand filters are already in place, because these achieve substantial cholera risk reductions on their own. On the other hand, implementing school-based cholera vaccination programs after the installation of boreholes with hand pump is more likely to be economically attractive. Also, if policymakers were to first invest in cholera vaccinations, then subsequently investing in water interventions is still likely to yield positive economic outcomes. This is because point-of-use water treatment delivers health benefits other than reduced cholera, and deep boreholes+hand pumps often yield non-health benefits such as time savings. However, cholera vaccination programs are much cheaper than the water supply interventions on a household basis. Donors and governments with limited budgets may thus determine that cholera vaccination programs are more equitable than water supply interventions because more people can receive benefits with a given budget. Practical considerations may also favor cholera vaccination programs in the densely crowded slums of South Asian and African cities where there may be insufficient space in housing units for some point-of-use technologies, and where non-networked water supply options are limited.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428925     DOI: 10.1016/j.vaccine.2009.02.104

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

Review 1.  Systematic review of the economic value of diarrheal vaccines.

Authors:  Richard Rheingans; Mirna Amaya; John D Anderson; Poulomy Chakraborty; Jacob Atem
Journal:  Hum Vaccin Immunother       Date:  2014-05-27       Impact factor: 3.452

2.  Global economic evaluation of oral cholera vaccine: A systematic review.

Authors:  Siew Li Teoh; Surachai Kotirum; Raymond C W Hutubessy; Nathorn Chaiyakunapruk
Journal:  Hum Vaccin Immunother       Date:  2017-12-15       Impact factor: 3.452

3.  Determinants of household costs associated with childhood diarrhea in 3 South Asian settings.

Authors:  Richard Rheingans; Matt Kukla; Abu Syed Golam Faruque; Dipika Sur; Anita K M Zaidi; Dilruba Nasrin; Tamer H Farag; Myron M Levine; Karen L Kotloff
Journal:  Clin Infect Dis       Date:  2012-12       Impact factor: 9.079

Review 4.  Meeting cholera's challenge to Haiti and the world: a joint statement on cholera prevention and care.

Authors:  Paul Farmer; Charles Patrick Almazor; Emily T Bahnsen; Donna Barry; Junior Bazile; Barry R Bloom; Niranjan Bose; Thomas Brewer; Stephen B Calderwood; John D Clemens; Alejandro Cravioto; Eddy Eustache; Gregory Jérôme; Neha Gupta; Jason B Harris; Howard H Hiatt; Cassia Holstein; Peter J Hotez; Louise C Ivers; Vanessa B Kerry; Serena P Koenig; Regina C Larocque; Fernet Léandre; Wesler Lambert; Evan Lyon; John J Mekalanos; Joia S Mukherjee; Cate Oswald; Jean-William Pape; Anany Gretchko Prosper; Regina Rabinovich; Maxi Raymonville; Jean-Renold Réjouit; Laurence J Ronan; Mark L Rosenberg; Edward T Ryan; Jeffrey D Sachs; David A Sack; Claude Surena; Arjun A Suri; Ralph Ternier; Matthew K Waldor; David Walton; Jonathan L Weigel
Journal:  PLoS Negl Trop Dis       Date:  2011-05-31

5.  The costs of climate change: a study of cholera in Tanzania.

Authors:  Sara L M Trærup; Ramon A Ortiz; Anil Markandya
Journal:  Int J Environ Res Public Health       Date:  2011-11-28       Impact factor: 3.390

Review 6.  Oral cholera vaccine development and use in Vietnam.

Authors:  Dang Duc Anh; Anna Lena Lopez; Hung Thi Mai Tran; Nguyen Van Cuong; Vu Dinh Thiem; Mohammad Ali; Jacqueline L Deen; Lorenz von Seidlein; David A Sack
Journal:  PLoS Med       Date:  2014-09-02       Impact factor: 11.069

Review 7.  Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries.

Authors:  Rohan Deogaonkar; Raymond Hutubessy; Inge van der Putten; Silvia Evers; Mark Jit
Journal:  BMC Public Health       Date:  2012-10-16       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.